Back to top

Image: Bigstock

Compared to Estimates, Camden (CPT) Q1 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended March 2026, Camden (CPT - Free Report) reported revenue of $388.77 million, down 0.5% over the same period last year. EPS came in at $1.70, compared to $0.36 in the year-ago quarter.

The reported revenue represents a surprise of -0.48% over the Zacks Consensus Estimate of $390.66 million. With the consensus EPS estimate being $1.67, the EPS surprise was +2.1%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Camden performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Rental revenues: $345.7 million versus $388.49 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -0.8% change.
  • Non-property income- Total: $1.24 million versus $4.38 million estimated by three analysts on average.
  • Non-property income- Interest and other income: $0.25 million versus $0.39 million estimated by three analysts on average.
  • Net Earnings per Share (Diluted): $0.40 compared to the $0.03 average estimate based on three analysts.
  • Non-property income- Fee and asset management: $2.14 million versus the three-analyst average estimate of $2 million.
  • Non-property income- Income/(loss) on deferred compensation plans: $-1.16 million versus the two-analyst average estimate of $2.98 million.

View all Key Company Metrics for Camden here>>>

Shares of Camden have returned +7.2% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in